MedPath

A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer

Completed
Conditions
Non-small Cell Lung Cancer
Interventions
Procedure: Surgery
Registration Number
NCT03429192
Lead Sponsor
Tianjin Chest Hospital
Brief Summary

A study to compare patient survivals in the N2 patients with non-small cell lung cancer in the subgroups of lymph skip metastases and non-skip metastases

Detailed Description

A multi-centre real-world non-interventional observational study to retrospectively collect the study data on patient demographic/tumor biological characteristics and clinical treatments to compare patient survivals in the N2 patients with non-small cell lung cancer in the subgroups of lymph skip metastases and non-skip metastases.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2653
Inclusion Criteria
  • Patients with surgeries from 2014 to 2017;
  • Pathologically diagnosed patients with non-small cell lung cancer;
  • Age > 18 years old;
  • Patients with chest surgeries before hospitalization;
  • Patients with N2 lymph nodes (+) after surgeries who received lymphadenectomy (Group 10 and 11 lymph nodes);
Exclusion Criteria
  • Patients with radiotherapies, chemotherapies and biological therapies for tumors

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
N2 non-small cell lung cancerSurgeryChinese patients with N2 non-small cell lung cancer
Primary Outcome Measures
NameTimeMethod
Difference in overall survival (OS)2014 - 2017

OS difference in the subgroups of N2 patients with lymph skip metastases and non-skip metastases

Secondary Outcome Measures
NameTimeMethod
Percentage of N2 patients with lymph skip metastases2014 - 2017

Percentage of N2 patients with lymph skip metastases

Trial Locations

Locations (9)

Jiangsu Cancer Hospital

🇨🇳

Nanjing, Jiangsu, China

China-Japan Friendship Hospital

🇨🇳

Beijing, Beijing, China

China People's Liberation Army Hospital

🇨🇳

Beijing, Beijing, China

Henan Cancer Hospital

🇨🇳

Zhengzhou, Henan, China

Tongji Hospital Affiliated to Huaxi Technology University

🇨🇳

Wuhan, Hubei, China

Shanghai Chest Hospital

🇨🇳

Shanghai, Shanghai, China

Xi'an Tangdu Hospital

🇨🇳

Xi'an, Shanghai, China

Huaxi Hospital Affiliate to Sichuan University

🇨🇳

Chengdu, Sichuan, China

First Hospital Affiliated to Zhejiang University

🇨🇳

Hangzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath